BACKGROUND
Oral anticoagulation (OAC) remains the cornerstone of stroke prevention in atrial fibrillation (AF) but is limited by bleeding risk. Left atrial appendage occlusion (LAAO) devices offer an alternative; however, recent randomized trials have reported inconsistent efficacy compared with OAC.
METHODS
We condu...
Z. Bashir, M. Abdul Rehman, Mohammad Hamza et al.· Pacing and clinical electrop...· 0 citations
Background:
Oral anticoagulation (OAC) remains the cornerstone of stroke prevention in atrial fibrillation (AF), but its use is limited by bleeding risk. Left atrial appendage occlusion (LAAO) devices offer a nonpharmacological alternative; however, recent randomized trials have reported inconsistent efficacy compar...
Z. Bashir, M. Abdul Rehman, M. Yang et al.· Circulation· 0 citations
Background Statins remain the cornerstone of pharmacological prevention for atherosclerotic cardiovascular disease (ASCVD) because of their proven ability to reduce low-density lipoprotein cholesterol (LDL-C) and major adverse cardiovascular events (MACE). However, many patients continue to experience ASCVD events desp...
Muhammad Abdul Rehman, M. O. Oduoye, D. J. Ozoemena et al.· Frontiers in Cardiovascular...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.